Latest filing published 28 Sept 2026 for Progyny, Inc., €89k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Allison Swartz discloses dealings in Progyny, Inc. to SEC (Form 4). In total, 31 filings cover trades dated from 28 November 2022 to 23 September 2026.
The open-market record consists of 9 sales worth €326k, with no purchase. Outside the open market, there are 22 share grants. Since January 2026: no purchases and 5 sales on the market.
The newest entry dates from 28 September 2026: an open-market sale of €89k, in Progyny, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations